Mimedx (MDXG) Prepaid Assets (2010 - 2026)
Mimedx (MDXG) posted Prepaid Assets of $7.3 million for Q2 2026, down 11.98% sequentially from $8.3 million in Q1 2026, and up 50.07% YoY from $4.9 million in Q2 2025.
Mimedx (MDXG) Prepaid Assets (2010 - 2026) Analysis & Trends
Mimedx has reported Prepaid Assets for 17 years, with the latest figure at $7.3 million in Q2 2026.
- Quarterly Prepaid Assets rose 50.07% year-over-year to $7.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.3 million (up 50.07% YoY) and the FY2025 annual result came in at $10.3 million, up 31.5% from the prior year.
- Prepaid Assets retreated to $7.3 million in Q2 2026 per MDXG's latest filing, from $8.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $10.3 million in Q4 2025 and troughed at $2.9 million in Q3 2024.
- A 5-year average of $5.8 million and a median of $5.5 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 125.17% in 2022, then tumbled 36.87% in 2023.
- Over 5 years, Prepaid Assets stood at $7.3 million in 2022, then dropped by 23.12% to $5.6 million in 2023, then surged by 39.31% to $7.8 million in 2024, then jumped by 31.5% to $10.3 million in 2025, then dropped by 29.17% to $7.3 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $7.3 million, $8.3 million, and $10.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.30 Mn |
| Mar 31, 2026 | 8.29 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Sep 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 7.84 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 4.03 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | 5.62 Mn |
| Sep 30, 2023 | 2.95 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 8.82 Mn |
| Dec 31, 2022 | 7.32 Mn |
| Sep 30, 2022 | 4.68 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | 6.14 Mn |
| Dec 31, 2021 | 6.15 Mn |
| Sep 30, 2021 | 2.08 Mn |